4.8 Article

Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2

期刊

NATURE GENETICS
卷 44, 期 12, 页码 1370-1374

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ng.2454

关键词

-

资金

  1. US National Institutes of Health (NIH) (National Institute of Neurological Disorders and Stroke (NINDS)) [P01NS069539]
  2. US National Institutes of Health (NIH) (Clinical & Translational Science Award (CTSA)) [UL1RR024160]
  3. US National Institutes of Health (NIH) (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)) [R01AR045203]
  4. US National Institutes of Health (NIH) (National Human Genome Research Institute (NHGRI)) [HG005608, HG006493]
  5. Netherlands Genomics Initiative (NGI) [93515504]
  6. University of Washington Center for Mendelian Genomics
  7. Muscular Dystrophy Association (MDA) [217596]
  8. Fields Center for FSHD Research
  9. Geraldi Norton and Eklund family foundation
  10. FSH Society
  11. Friends of FSH Research
  12. European Union [223026, 223143, 2012-305121]
  13. Stichting FSHD
  14. China Scholarship Council

向作者/读者索取更多资源

Facioscapulohumeral dystrophy (FSHD) is characterized by chromatin relaxation of the D4Z4 macrosatellite array on chromosome 4 and expression of the D4Z4-encoded DUX4 gene in skeletal muscle. The more common form, autosomal dominant FSHD1, is caused by contraction of the D4Z4 array, whereas the genetic determinants and inheritance of D4Z4 array contraction-independent FSHD2 are unclear. Here, we show that mutations in SMCHD1 (encoding structural maintenance of chromosomes flexible hinge domain containing 1) on chromosome 18 reduce SMCHD1 protein levels and segregate with genome-wide D4Z4 CpG hypomethylation in human kindreds. FSHD2 occurs in individuals who inherited both the SMCHD1 mutation and a normal-sized D4Z4 array on a chromosome 4 haplotype permissive for DUX4 expression. Reducing SMCHD1 levels in skeletal muscle results in D4Z4 contraction-independent DUX4 expression. Our study identifies SMCHD1 as an epigenetic modifier of the D4Z4 metastable epiallele and as a causal genetic determinant of FSHD2 and possibly other human diseases subject to epigenetic regulation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据